Dog-Assisted Therapy for Children and Adolescents With FASD

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

39 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-02

Study Completion Date

2019-04-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The rationale of the present study was to evaluate the efficacy of DAT in children and adolescents with FASD in relation to its effects on social skills, internalized and externalized symptomatology and on severity of FASD symptoms. This objective was accomplished through a randomized controlled pilot study of DAT for children and adolescents with FASD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dog Assisted Therapy: Comparing Duration Treatments for Patients with Fetal Alcohol Spectrum Disorder

NCT06763614

Fetal Alcohol Spectrum Disorders

COMPLETED NA

Dog Assisted Therapy Program for Children With ADHD

NCT06496685

Attention Deficit Disorder With Hyperactivity Animal Assisted Therapy

COMPLETED NA

Translating Peer-to-Peer Support Into a Clinical Setting

NCT04313283

Development Delay Neurodevelopmental Disorders Autism

COMPLETED NA

Animal-Assisted Therapy in Pediatric Autism Spectrum Disorders

NCT06687850

Pediatric Autism Developmental Delay (Disorder) Behavioral Concerns

COMPLETED NA

Animal Assisted Intervention With Dogs for Children With ADHD

NCT05102344

Attention Deficit Hyperactivity Disorder

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The rationale of this study was to evaluate the efficacy of Dog Assisted Therapy in children and adolescents with FASD. The investigators conducted a randomized, rater-blinded, controlled pilot trial in a cohort of 33 children and adolescents with FASD. Participants were randomly assigned either to DAT group (n=17) or Treatment as Usual (TAU control group) (n=16). The investigators evaluated changes on social skills, internalized and externalized symptomatology and on severity of FASD symptoms at pre-treatment and post-treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

FASD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The design was a randomized, rater-blinded, controlled pilot trial. Participants were randomly assigned either to DAT group (n=17) or Treatment as Usual (TAU control group) (n=16).

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Rater-blinded

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dog-Assisted Therapy (DAT) and pharmacological treatment

The DAT program comprised 12 manualized sessions and included two phases: 1) individual intervention (6 sessions) and 2) group activity (6 sessions). Patients participated in weekly sessions for about 3 months. Each session lasted 45 minutes. The groups were formed by 3-4 patients. Sessions included the participation of two certified therapy dogs, two technicians specialized in DAT and a psychologist. Participants in this group were visited by their psychiatrist in order to monitor their adherence to medications.

Group Type EXPERIMENTAL

Dog-Assisted Therapy and pharmacological treatment

Intervention Type BEHAVIORAL

The investigators used the CTAC Method (Center of Dog Assisted Therapy) (E Domènec 2012).

Treatment as usual (TAU, pharmacological treatment)

Participants received their usual treatment. They were visited by their psychiatrist in order to monitor their adherence and continuation on medications as prescribed. Inclusion and exclusion criteria were the same as for the experimental group. Participants in the TAU group did not receive DAT sessions.

Group Type ACTIVE_COMPARATOR

Dog-Assisted Therapy and pharmacological treatment

Intervention Type BEHAVIORAL

The investigators used the CTAC Method (Center of Dog Assisted Therapy) (E Domènec 2012).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dog-Assisted Therapy and pharmacological treatment

The investigators used the CTAC Method (Center of Dog Assisted Therapy) (E Domènec 2012).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with FASD between 6 and 18 years (FAS, pFAS or ARND)
* With or without comorbidities
* Stabilized doses of medication for at least 2 months before the study
* Patients with borderline IQ or mental retardation.